Sponsor:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
Notices
- Notice of Change to Instructions for NOT-OD-18-195 "Notice of Availability of Administrative Supplements for NIH Grants Focused on Down Syndrome to Address Specific Down Syndrome Research Objectives"
Office of the Director, NIH
National Center for Advancing Translational Sciences
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research - Notice of Change to Instructions for NOT-OD-18-194 "Notice of Availability of Administrative Supplements for NIH Grants that are NOT Focused on Down Syndrome to Address Specific Down Syndrome Research Objectives
Office of the Director, NIH
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research - Notice Announcing FAQs Page for PAR-18-307 "Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional)" and PAR-18-324 "Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)"
Office of the Director, NIH - Notice of Change to the Research Areas of Focus for PAR-17-267 "Modeling of Infectious Disease Agent Study Research Projects (R01)"
National Institute of Allergy and Infectious Diseases - NIAID OMNIBUS BROAD AGENCY ANNOUNCEMENT No. HHS-NIH-NIAID-BAA2018: Soliciting Proposals for Antimicrobial Products, Novel Vaccines and Technologies Against Category A, B, and C Agents, and Universal Influenza Vaccines
National Institute of Allergy and Infectious Diseases - Notice of NCI Participation in PA-18-343, "Academic Research Enhancement Award (R15 Clinical Trial Required)"
National Cancer Institute - Notice of Change of Requirements for RFA-DA-19-002, "Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional)
National Institute on Drug Abuse - Notice of Intent to Publish a Funding Opportunity Announcement for The National Drug Abuse Treatment Clinical Trials Network (UG1) Clinical Trial Optional
National Institute on Drug Abuse - Notice of NIDCD and NEI Interest in Supporting Research on Usher Syndrome
National Institute on Deafness and Other Communication Disorders
National Eye Institute - Notice of Clarification of Eligible Individuals [Program Director(s)/Principal Investigator(s)] for RFA-DK-18-009, Gastrointestinal Mechanisms Contributing to HIV Pathogenesis (R01 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases - Notice of NICHD Participation in PAR-17-471 "Detection of HIV for Self-Testing (R61/R33)"
Eunice Kennedy Shriver National Institute of Child Health and Human Development - Notice of Change to Due Date and Foreign Institutions Eligibility for Applications to RFA-HD-19-018: Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed)
Eunice Kennedy Shriver National Institute of Child Health and Human Development - Notice of NHGRI Interest in Receiving Letters Requesting Permission to Submit Applications to Support Biennial ELSI Research Conferences (U13)
National Human Genome Research Institute - NHLBI Announces Participation in PA-17-444 "Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R01)"
National Heart, Lung, and Blood Institute - Notice of NHLBI Participation in PA-18-723 "Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional)"
National Heart, Lung, and Blood Institute - Notice of NHLBI Participation in PA-18-722 "Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional)"
National Heart, Lung, and Blood Institute - Notice of Information for HIV research priorities at the National Heart, Lung, and Blood Institute
National Heart, Lung, and Blood Institute - Notice of Intent to Publish Funding Opportunity Announcement to Promote Screening and Management of Unhealthy Alcohol Use in Primary Care (R18)
Agency for Healthcare Research and Quality - Request for Information (RFI): Challenges and Opportunities in Understanding Nuclear Organization in Space and Time (4D Nucleome)
Office of Strategic Coordination (Common Fund)
Requests for Applications
- Leadership Group for a Clinical Research Network on Antibacterial Resistance (UM1 Clinical Trial Required)
National Institute of Allergy and Infectious Diseases
- Limited Competition: NIDCD National Temporal Bone, Hearing and Balance Pathology Resource Registry (U24 Clinical Trial Not Allowed)
Only recipient organizations previously funded under RFA-DC-14-002 are eligible to apply.
National Institute on Deafness and Other Communication Disorders
- Encouraging Development of Novel Amelogenesis Models (UG3/UH3 Clinical Trial Not Allowed)
National Institute of Dental and Craniofacial Research
Program Announcements
- Prevention Research in Mid-Life Adults (R01 Clinical Trial Optional)
- Prevention Research in Mid-Life Adults (R21 Clinical Trial Optional)
National Institute of Nursing Research
National Institute on Aging
- NIBIB Supplements to NCATS CTSA Programs to Support NIBIB Translational Research Scholars (Admin Supp Clinical Trials Optional)
National Institute of Biomedical Imaging and Bioengineering
** Limited to two applications per institution.
UIowa applicants are requested to contact Deanna O'Quinn deanna-oquinn@uiowa.edu in UIowa ICTS Administration by Nov. 12, 2018.
- Drug Transport Across the Blood-Testis and Blood-Epididymal Barriers (R61/R33 - Clinical Trial Not Allowed)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of Behavioral and Social Science Research
Office of Disease Prevention
Details, including application deadlines, when applicable, are available through the program links above. To view the full NIH Guide, present and/or past, please visit http://grants1.nih.gov/grants/guide/index.html
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at 335-2123, or email Linda Meyer at linda-k-meyer@uiowa.edu, Paul Below at paul-below@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu